-
1
-
-
84904791071
-
RAF signaling in neuroendocrine neoplasms: From bench to bedside
-
Fazio N, Abdel-Rahman O, Spada F, Galdy S, De Dosso S, Capdevila J and Scarpa A. RAF signaling in neuroendocrine neoplasms: From bench to bedside. Cancer Treat Rev. 2014.
-
(2014)
Cancer Treat Rev
-
-
Fazio, N.1
Abdel-Rahman, O.2
Spada, F.3
Galdy, S.4
De Dosso, S.5
Capdevila, J.6
Scarpa, A.7
-
2
-
-
52449104598
-
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors
-
Modlin IM, Moss SF, Chung DC, Jensen RT and Snyderwine E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst. 2008; 100(18):1282-1289.
-
(2008)
J Natl Cancer Inst.
, vol.100
, Issue.18
, pp. 1282-1289
-
-
Modlin, I.M.1
Moss, S.F.2
Chung, D.C.3
Jensen, R.T.4
Snyderwine, E.5
-
3
-
-
47149104096
-
Bronchopulmonary neuroendocrine tumors
-
Gustafsson BI, Kidd M, Chan A, Malfertheiner MV and Modlin IM. Bronchopulmonary neuroendocrine tumors. Cancer. 2008; 113(1):5-21.
-
(2008)
Cancer.
, vol.113
, Issue.1
, pp. 5-21
-
-
Gustafsson, B.I.1
Kidd, M.2
Chan, A.3
Malfertheiner, M.V.4
Modlin, I.M.5
-
4
-
-
84856007087
-
[Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]
-
Horsch D, Sayeg Y, Bonnet R, Kaemmerer D, Presselt N and Baum RP. [Expert dialogue: neuroendocrine tumours of the lungs and gastroenteropancreatic system]. Pneumologie. 2012; 66(1):44-48.
-
(2012)
Pneumologie.
, vol.66
, Issue.1
, pp. 44-48
-
-
Horsch, D.1
Sayeg, Y.2
Bonnet, R.3
Kaemmerer, D.4
Presselt, N.5
Baum, R.P.6
-
5
-
-
79952537453
-
Carcinoid lung tumors-incidence, treatment and outcomes: a population-based study
-
Naalsund A, Rostad H, Strom EH, Lund MB and Strand TE. Carcinoid lung tumors-incidence, treatment and outcomes: a population-based study. Eur J Cardiothorac Surg. 2011; 39(4):565-569.
-
(2011)
Eur J Cardiothorac Surg.
, vol.39
, Issue.4
, pp. 565-569
-
-
Naalsund, A.1
Rostad, H.2
Strom, E.H.3
Lund, M.B.4
Strand, T.E.5
-
6
-
-
67049164175
-
Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids
-
Ferolla P, Daddi N, Urbani M, Semeraro A, Ribacchi R, Giovenali P, Ascani S, De Angelis V, Crino L, Puma F and Daddi G. Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids. J Thorac Oncol. 2009; 4(3):383-387.
-
(2009)
J Thorac Oncol.
, vol.4
, Issue.3
, pp. 383-387
-
-
Ferolla, P.1
Daddi, N.2
Urbani, M.3
Semeraro, A.4
Ribacchi, R.5
Giovenali, P.6
Ascani, S.7
De Angelis, V.8
Crino, L.9
Puma, F.10
Daddi, G.11
-
7
-
-
84893958990
-
Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009
-
Luchtenborg M, Riaz SP, Lim E, Page R, Baldwin DR, Jakobsen E, Vedsted P, Lind M, Peake MD, Mellemgaard A, Spicer J, Lang-Lazdunski L and Moller H. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998-2009. Thorax. 2013; 69(3):269- 273.
-
(2013)
Thorax.
, vol.69
, Issue.3
, pp. 269- 273
-
-
Luchtenborg, M.1
Riaz, S.P.2
Lim, E.3
Page, R.4
Baldwin, D.R.5
Jakobsen, E.6
Vedsted, P.7
Lind, M.8
Peake, M.D.9
Mellemgaard, A.10
Spicer, J.11
Lang-Lazdunski, L.12
Moller, H.13
-
8
-
-
2542491088
-
[Bronchial carcinoid tumor: a retrospective analysis of 62 surgically treated cases]
-
Iglesias M, Belda J, Baldo X, Gimferrer JM, Catalan M, Rubio M and Serra M. [Bronchial carcinoid tumor: a retrospective analysis of 62 surgically treated cases]. Arch Bronconeumol. 2004; 40(5):218-221.
-
(2004)
Arch Bronconeumol.
, vol.40
, Issue.5
, pp. 218-221
-
-
Iglesias, M.1
Belda, J.2
Baldo, X.3
Gimferrer, J.M.4
Catalan, M.5
Rubio, M.6
Serra, M.7
-
9
-
-
1942500905
-
Bronchial carcinoid tumors: nodal status and long-term survival after resection
-
Cardillo G, Sera F, Di Martino M, Graziano P, Giunti R, Carbone L, Facciolo F and Martelli M. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg. 2004; 77(5):1781-1785.
-
(2004)
Ann Thorac Surg.
, vol.77
, Issue.5
, pp. 1781-1785
-
-
Cardillo, G.1
Sera, F.2
Di Martino, M.3
Graziano, P.4
Giunti, R.5
Carbone, L.6
Facciolo, F.7
Martelli, M.8
-
11
-
-
36148957078
-
Discovery of small molecule CXCR4 antagonists
-
Zhan W, Liang Z, Zhu A, Kurtkaya S, Shim H, Snyder JP and Liotta DC. Discovery of small molecule CXCR4 antagonists. J Med Chem. 2007; 50(23):5655-5664.
-
(2007)
J Med Chem.
, vol.50
, Issue.23
, pp. 5655-5664
-
-
Zhan, W.1
Liang, Z.2
Zhu, A.3
Kurtkaya, S.4
Shim, H.5
Snyder, J.P.6
Liotta, D.C.7
-
12
-
-
77953090345
-
CXCL12 (SDF-1)/CXCR4 pathway in cancer
-
Teicher BA and Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 2010; 16(11):2927-2931.
-
(2010)
Clin Cancer Res.
, vol.16
, Issue.11
, pp. 2927-2931
-
-
Teicher, B.A.1
Fricker, S.P.2
-
13
-
-
61449451621
-
The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer
-
Otsuka S and Bebb G. The CXCR4/SDF-1 chemokine receptor axis: a new target therapeutic for non-small cell lung cancer. J Thorac Oncol. 2008; 3(12):1379-1383.
-
(2008)
J Thorac Oncol.
, vol.3
, Issue.12
, pp. 1379-1383
-
-
Otsuka, S.1
Bebb, G.2
-
14
-
-
34250896780
-
The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells
-
Faber A, Roderburg C, Wein F, Saffrich R, Seckinger A, Horsch K, Diehlmann A, Wong D, Bridger G, Eckstein V, Ho AD and Wagner W. The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells. J Biomed Biotechnol. 2007; 2007(3):26065.
-
(2007)
J Biomed Biotechnol.
, vol.2007
, Issue.3
, pp. 26065
-
-
Faber, A.1
Roderburg, C.2
Wein, F.3
Saffrich, R.4
Seckinger, A.5
Horsch, K.6
Diehlmann, A.7
Wong, D.8
Bridger, G.9
Eckstein, V.10
Ho, A.D.11
Wagner, W.12
-
15
-
-
3042822267
-
Cancer and the chemokine network
-
Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004; 4(7):540-550.
-
(2004)
Nat Rev Cancer.
, vol.4
, Issue.7
, pp. 540-550
-
-
Balkwill, F.1
-
16
-
-
84923299963
-
The chemokine receptor CXCR4 is associated with the staging of gastric cancer
-
Nikzaban M, Hakhamaneshi MS, Fakhari S, Sheikhesmaili F, Roshani D, Ahsan B, Kamali F and Jalili A. The chemokine receptor CXCR4 is associated with the staging of gastric cancer. Adv Biomed Res. 2014; 3:16.
-
(2014)
Adv Biomed Res.
, vol.3
, pp. 16
-
-
Nikzaban, M.1
Hakhamaneshi, M.S.2
Fakhari, S.3
Sheikhesmaili, F.4
Roshani, D.5
Ahsan, B.6
Kamali, F.7
Jalili, A.8
-
17
-
-
84883176178
-
CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential
-
Wald O, Shapira OM and Izhar U. CXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential. Theranostics. 2013; 3(1):26-33.
-
(2013)
Theranostics.
, vol.3
, Issue.1
, pp. 26-33
-
-
Wald, O.1
Shapira, O.M.2
Izhar, U.3
-
18
-
-
84902982175
-
CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer
-
Gao Y, Li C, Nie M, Lu Y, Lin S, Yuan P and Sun X. CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer. Tumour Biol. 2014.
-
(2014)
Tumour Biol
-
-
Gao, Y.1
Li, C.2
Nie, M.3
Lu, Y.4
Lin, S.5
Yuan, P.6
Sun, X.7
-
20
-
-
84896878080
-
Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4
-
Aghanejad A, Jalilian AR, Fazaeli Y, Alirezapoor B, Pouladi M, Beiki D, Maus S and Khalaj A. Synthesis and Evaluation of [(67)Ga]-AMD3100: A Novel Imaging Agent for Targeting the Chemokine Receptor CXCR4. Sci Pharm. 2013; 82(1):29-42.
-
(2013)
Sci Pharm.
, vol.82
, Issue.1
, pp. 29-42
-
-
Aghanejad, A.1
Jalilian, A.R.2
Fazaeli, Y.3
Alirezapoor, B.4
Pouladi, M.5
Beiki, D.6
Maus, S.7
Khalaj, A.8
-
21
-
-
80455129812
-
PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent
-
Gourni E, Demmer O, Schottelius M, D'Alessandria C, Schulz S, Dijkgraaf I, Schumacher U, Schwaiger M, Kessler H and Wester HJ. PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent. J Nucl Med. 2011; 52(11):1803-1810.
-
(2011)
J Nucl Med.
, vol.52
, Issue.11
, pp. 1803-1810
-
-
Gourni, E.1
Demmer, O.2
Schottelius, M.3
D'Alessandria, C.4
Schulz, S.5
Dijkgraaf, I.6
Schumacher, U.7
Schwaiger, M.8
Kessler, H.9
Wester, H.J.10
-
22
-
-
84867581563
-
Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016
-
Otani Y, Kijima T, Kohmo S, Oishi S, Minami T, Nagatomo I, Takahashi R, Hirata H, Suzuki M, Inoue K, Takeda Y, Kida H, Tachibana I, Fujii N and Kumanogoh A. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016. FEBS Lett. 2012; 586(20):3639-3644.
-
(2012)
FEBS Lett.
, vol.586
, Issue.20
, pp. 3639-3644
-
-
Otani, Y.1
Kijima, T.2
Kohmo, S.3
Oishi, S.4
Minami, T.5
Nagatomo, I.6
Takahashi, R.7
Hirata, H.8
Suzuki, M.9
Inoue, K.10
Takeda, Y.11
Kida, H.12
Tachibana, I.13
Fujii, N.14
Kumanogoh, A.15
-
23
-
-
84892949720
-
Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis
-
Wong D, Kandagatla P, Korz W and Chinni SR. Targeting CXCR4 with CTCE-9908 inhibits prostate tumor metastasis. BMC Urol. 2014; 14:12.
-
(2014)
BMC Urol.
, vol.14
, pp. 12
-
-
Wong, D.1
Kandagatla, P.2
Korz, W.3
Chinni, S.R.4
-
24
-
-
84874629395
-
The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivo
-
Ling X, Spaeth E, Chen Y, Shi Y, Zhang W, Schober W, Hail N, Jr., Konopleva M and Andreeff M. The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivo. PLoS One. 2013; 8(3):e58426.
-
(2013)
PLoS One.
, vol.8
, Issue.3
-
-
Ling, X.1
Spaeth, E.2
Chen, Y.3
Shi, Y.4
Zhang, W.5
Schober, W.6
Hail, N.7
Konopleva, M.8
Andreeff, M.9
-
25
-
-
84906055425
-
The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
-
Weitzenfeld P and Ben-Baruch A. The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. Cancer Lett. 2013.
-
(2013)
Cancer Lett
-
-
Weitzenfeld, P.1
Ben-Baruch, A.2
-
26
-
-
21744433347
-
CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells
-
Hartmann TN, Burger JA, Glodek A, Fujii N and Burger M. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene. 2005; 24(27):4462-4471.
-
(2005)
Oncogene.
, vol.24
, Issue.27
, pp. 4462-4471
-
-
Hartmann, T.N.1
Burger, J.A.2
Glodek, A.3
Fujii, N.4
Burger, M.5
-
27
-
-
5744220122
-
The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer
-
Hartmann TN, Burger M and Burger JA. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer. J Biol Regul Homeost Agents. 2004; 18(2):126-130.
-
(2004)
J Biol Regul Homeost Agents.
, vol.18
, Issue.2
, pp. 126-130
-
-
Hartmann, T.N.1
Burger, M.2
Burger, J.A.3
-
28
-
-
2342432307
-
Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome
-
Spano JP, Andre F, Morat L, Sabatier L, Besse B, Combadiere C, Deterre P, Martin A, Azorin J, Valeyre D, Khayat D, Le Chevalier T and Soria JC. Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome. Ann Oncol. 2004; 15(4):613-617.
-
(2004)
Ann Oncol.
, vol.15
, Issue.4
, pp. 613-617
-
-
Spano, J.P.1
Andre, F.2
Morat, L.3
Sabatier, L.4
Besse, B.5
Combadiere, C.6
Deterre, P.7
Martin, A.8
Azorin, J.9
Valeyre, D.10
Khayat, D.11
Le Chevalier, T.12
Soria, J.C.13
-
29
-
-
77956404592
-
Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma
-
Clements D, Markwick LJ, Puri N and Johnson SR. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma. J Immunol. 2010; 185(3):1812-1821.
-
(2010)
J Immunol.
, vol.185
, Issue.3
, pp. 1812-1821
-
-
Clements, D.1
Markwick, L.J.2
Puri, N.3
Johnson, S.R.4
-
30
-
-
0036164742
-
Bronchial carcinoid tumors: surgical management and long-term outcome
-
Filosso PL, Rena O, Donati G, Casadio C, Ruffini E, Papalia E, Oliaro A and Maggi G. Bronchial carcinoid tumors: surgical management and long-term outcome. J Thorac Cardiovasc Surg. 2002; 123(2):303-309.
-
(2002)
J Thorac Cardiovasc Surg.
, vol.123
, Issue.2
, pp. 303-309
-
-
Filosso, P.L.1
Rena, O.2
Donati, G.3
Casadio, C.4
Ruffini, E.5
Papalia, E.6
Oliaro, A.7
Maggi, G.8
-
31
-
-
47049119185
-
Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study
-
Hassan MM, Phan A, Li D, Dagohoy CG, Leary C and Yao JC. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study. Int J Cancer. 2008; 123(4):867-873.
-
(2008)
Int J Cancer.
, vol.123
, Issue.4
, pp. 867-873
-
-
Hassan, M.M.1
Phan, A.2
Li, D.3
Dagohoy, C.G.4
Leary, C.5
Yao, J.C.6
-
32
-
-
84879844546
-
[Bronchial carcinoid tumor: study of 60 patients]
-
Madrid-Carbajal C, Garcia-Clemente M, Pando-Sandoval A, Cubillas Martin H, Gonzalez-Budino T and Casan-Clara P. [Bronchial carcinoid tumor: study of 60 patients]. Med Clin (Barc). 2013; 141(2):73-76.
-
(2013)
Med Clin (Barc).
, vol.141
, Issue.2
, pp. 73-76
-
-
Madrid-Carbajal, C.1
Garcia-Clemente, M.2
Pando-Sandoval, A.3
Cubillas Martin, H.4
Gonzalez-Budino, T.5
Casan-Clara, P.6
-
33
-
-
0033175215
-
Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties
-
Soga J and Yakuwa Y. Bronchopulmonary carcinoids: An analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg. 1999; 5(4):211-219.
-
(1999)
Ann Thorac Cardiovasc Surg.
, vol.5
, Issue.4
, pp. 211-219
-
-
Soga, J.1
Yakuwa, Y.2
-
34
-
-
66649093881
-
Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer
-
Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, Wada H, Date H and Miyahara R. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer. 2009; 115(11):2580-2593.
-
(2009)
Cancer.
, vol.115
, Issue.11
, pp. 2580-2593
-
-
Iwakiri, S.1
Mino, N.2
Takahashi, T.3
Sonobe, M.4
Nagai, S.5
Okubo, K.6
Wada, H.7
Date, H.8
Miyahara, R.9
-
35
-
-
79959906050
-
CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer
-
Otsuka S, Klimowicz AC, Kopciuk K, Petrillo SK, Konno M, Hao D, Muzik H, Stolte E, Boland W, Morris D, Magliocco AM and Bebb DG. CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer. J Thorac Oncol. 2011; 6(7):1169-1178.
-
(2011)
J Thorac Oncol.
, vol.6
, Issue.7
, pp. 1169-1178
-
-
Otsuka, S.1
Klimowicz, A.C.2
Kopciuk, K.3
Petrillo, S.K.4
Konno, M.5
Hao, D.6
Muzik, H.7
Stolte, E.8
Boland, W.9
Morris, D.10
Magliocco, A.M.11
Bebb, D.G.12
-
36
-
-
60949093573
-
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival
-
Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, Rengifo T, Sica GL, Port JL, Lee PC, Paul S, Altorki NK and Saqi A. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg. 2009; 137(3):615- 621.
-
(2009)
J Thorac Cardiovasc Surg.
, vol.137
, Issue.3
, pp. 615- 621
-
-
Wagner, P.L.1
Hyjek, E.2
Vazquez, M.F.3
Meherally, D.4
Liu, Y.F.5
Chadwick, P.A.6
Rengifo, T.7
Sica, G.L.8
Port, J.L.9
Lee, P.C.10
Paul, S.11
Altorki, N.K.12
Saqi, A.13
-
37
-
-
84892369037
-
Targets in small cell lung cancer
-
Teicher BA. Targets in small cell lung cancer. Biochem Pharmacol. 2014; 87(2):211-219.
-
(2014)
Biochem Pharmacol.
, vol.87
, Issue.2
, pp. 211-219
-
-
Teicher, B.A.1
-
38
-
-
84881188351
-
Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer
-
He H, Wang C, Shen Z, Fang Y, Wang X, Chen W, Liu F, Qin X and Sun Y. Upregulated expression of C-X-C chemokine receptor 4 is an independent prognostic predictor for patients with gastric cancer. PLoS One. 2013; 8(8):e71864.
-
(2013)
PLoS One.
, vol.8
, Issue.8
-
-
He, H.1
Wang, C.2
Shen, Z.3
Fang, Y.4
Wang, X.5
Chen, W.6
Liu, F.7
Qin, X.8
Sun, Y.9
-
39
-
-
84905120048
-
Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic Cavity
-
Okoye CC, Jablons DM, Jahan TM, Kukreja J, Cardozo S and Yom SS. Divergent Management Strategies for Typical Versus Atypical Carcinoid Tumors of the Thoracic Cavity. Am J Clin Oncol. 2013.
-
(2013)
Am J Clin Oncol
-
-
Okoye, C.C.1
Jablons, D.M.2
Jahan, T.M.3
Kukreja, J.4
Cardozo, S.5
Yom, S.S.6
-
40
-
-
84874712239
-
Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer
-
Al Zobair AA, Al Obeidy BF, Yang L, Yang C, Hui Y, Yu H, Zheng F, Yang G, Xie C, Zhou F and Zhou Y. Concomitant overexpression of EGFR and CXCR4 is associated with worse prognosis in a new molecular subtype of non-small cell lung cancer. Oncol Rep. 2013; 29(4):1524-1532.
-
(2013)
Oncol Rep.
, vol.29
, Issue.4
, pp. 1524-1532
-
-
Al Zobair, A.A.1
Al Obeidy, B.F.2
Yang, L.3
Yang, C.4
Hui, Y.5
Yu, H.6
Zheng, F.7
Yang, G.8
Xie, C.9
Zhou, F.10
Zhou, Y.11
-
41
-
-
85039893932
-
The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis
-
Lv S, Yang Y, Kwon S, Han M, Zhao F, Kang H, Dai C and Wang R. The association of CXCR4 expression with prognosis and clinicopathological indicators in colorectal carcinoma patients: a meta-analysis. Histopathology. 2013.
-
(2013)
Histopathology
-
-
Lv, S.1
Yang, Y.2
Kwon, S.3
Han, M.4
Zhao, F.5
Kang, H.6
Dai, C.7
Wang, R.8
-
42
-
-
58149350094
-
Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2
-
Fischer T, Nagel F, Jacobs S, Stumm R and Schulz S. Reassessment of CXCR4 chemokine receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-2. PLoS One. 2008; 3(12):e4069.
-
(2008)
PLoS One.
, vol.3
, Issue.12
-
-
Fischer, T.1
Nagel, F.2
Jacobs, S.3
Stumm, R.4
Schulz, S.5
-
43
-
-
0032850917
-
Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies
-
de Cremoux P, Martin EC, Vincent-Salomon A, Dieras V, Barbaroux C, Liva S, Pouillart P, Sastre-Garau X and Magdelenat H. Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185(HER2/neu) protein expression in breast cancer drill biopsies. Int J Cancer. 1999; 83(2):157-161.
-
(1999)
Int J Cancer.
, vol.83
, Issue.2
, pp. 157-161
-
-
de Cremoux, P.1
Martin, E.C.2
Vincent-Salomon, A.3
Dieras, V.4
Barbaroux, C.5
Liva, S.6
Pouillart, P.7
Sastre-Garau, X.8
Magdelenat, H.9
-
44
-
-
84883187912
-
Molecular imaging of chemokine receptor CXCR4
-
Weiss ID and Jacobson O. Molecular imaging of chemokine receptor CXCR4. Theranostics. 2013; 3(1):76-84.
-
(2013)
Theranostics.
, vol.3
, Issue.1
, pp. 76-84
-
-
Weiss, I.D.1
Jacobson, O.2
-
45
-
-
39049113016
-
[Establishment of a CXCR4-expressing gastric cancer cell line in nude mice and the effect of AMD 3100 on tumor regression]
-
Iwanaga T, Iwasaki Y, Ohashi M, Nunobe S and Iwagami S. [Establishment of a CXCR4-expressing gastric cancer cell line in nude mice and the effect of AMD 3100 on tumor regression]. Gan To Kagaku Ryoho. 2007; 34(12):1917- 1919.
-
(2007)
Gan To Kagaku Ryoho.
, vol.34
, Issue.12
, pp. 1917- 1919
-
-
Iwanaga, T.1
Iwasaki, Y.2
Ohashi, M.3
Nunobe, S.4
Iwagami, S.5
-
46
-
-
26844527356
-
CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer
-
Saur D, Seidler B, Schneider G, Algul H, Beck R, Senekowitsch-Schmidtke R, Schwaiger M and Schmid RM. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology. 2005; 129(4):1237-1250.
-
(2005)
Gastroenterology.
, vol.129
, Issue.4
, pp. 1237-1250
-
-
Saur, D.1
Seidler, B.2
Schneider, G.3
Algul, H.4
Beck, R.5
Senekowitsch-Schmidtke, R.6
Schwaiger, M.7
Schmid, R.M.8
-
47
-
-
84892369037
-
Targets in small cell lung cancer
-
Teicher BA. Targets in small cell lung cancer. Biochem Pharmacol. 2013; 87(2):211-219.
-
(2013)
Biochem Pharmacol.
, vol.87
, Issue.2
, pp. 211-219
-
-
Teicher, B.A.1
-
48
-
-
77955216385
-
NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: welldifferentiated neuroendocrine tumors of the thorax (includes lung and thymus)
-
Phan AT, Oberg K, Choi J, Harrison LH, Jr., Hassan MM, Strosberg JR, Krenning EP, Kocha W, Woltering EA and Maples WJ. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: welldifferentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas. 2010; 39(6):784-798.
-
(2010)
Pancreas.
, vol.39
, Issue.6
, pp. 784-798
-
-
Phan, A.T.1
Oberg, K.2
Choi, J.3
Harrison, L.H.4
Hassan, M.M.5
Strosberg, J.R.6
Krenning, E.P.7
Kocha, W.8
Woltering, E.A.9
Maples, W.J.10
-
49
-
-
0023340925
-
[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ERICA) in breast cancer tissue]
-
Remmele W and Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ERICA) in breast cancer tissue]. Pathologe. 1987; 8(3):138- 140.
-
(1987)
Pathologe.
, vol.8
, Issue.3
, pp. 138- 140
-
-
Remmele, W.1
Stegner, H.E.2
-
50
-
-
79954644097
-
Prognostic utility of betatubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study
-
Pentheroudakis G, Batistatou A, Kalogeras KT, Kronenwett R, Wirtz RM, Bournakis E, Eleftheraki AG, Pectasides D, Bobos M, Papaspirou I, Kamina S, Gogas H, Koutras AK, Pavlidis N and Fountzilas G. Prognostic utility of betatubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study. Breast Cancer Res Treat. 2011; 127(1):179-193.
-
(2011)
Breast Cancer Res Treat.
, vol.127
, Issue.1
, pp. 179-193
-
-
Pentheroudakis, G.1
Batistatou, A.2
Kalogeras, K.T.3
Kronenwett, R.4
Wirtz, R.M.5
Bournakis, E.6
Eleftheraki, A.G.7
Pectasides, D.8
Bobos, M.9
Papaspirou, I.10
Kamina, S.11
Gogas, H.12
Koutras, A.K.13
Pavlidis, N.14
Fountzilas, G.15
-
51
-
-
69549108768
-
RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods
-
Bohmann K, Hennig G, Rogel U, Poremba C, Mueller BM, Fritz P, Stoerkel S and Schaefer KL. RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods. Clin Chem. 2009; 55(9):1719-1727.
-
(2009)
Clin Chem.
, vol.55
, Issue.9
, pp. 1719-1727
-
-
Bohmann, K.1
Hennig, G.2
Rogel, U.3
Poremba, C.4
Mueller, B.M.5
Fritz, P.6
Stoerkel, S.7
Schaefer, K.L.8
-
52
-
-
84895919165
-
The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer
-
Atmaca A, Al-Batran SE, Wirtz RM, Werner D, Zirlik S, Wiest G, Eschbach C, Claas S, Hartmann A, Ficker JH, Jager E and Brueckl WM. The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer. Int J Cancer. 2014; 134(10):2314-2321.
-
(2014)
Int J Cancer.
, vol.134
, Issue.10
, pp. 2314-2321
-
-
Atmaca, A.1
Al-Batran, S.E.2
Wirtz, R.M.3
Werner, D.4
Zirlik, S.5
Wiest, G.6
Eschbach, C.7
Claas, S.8
Hartmann, A.9
Ficker, J.H.10
Jager, E.11
Brueckl, W.M.12
-
53
-
-
84874557633
-
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
-
Denkert C, Loibl S, Kronenwett R, Budczies J, von Torne C, Nekljudova V, Darb-Esfahani S, Solbach C, Sinn BV, Petry C, Muller BM, Hilfrich J, Altmann G, Staebler A, Roth C, Ataseven B, et al. RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy. Ann Oncol. 2013; 24(3):632-639.
-
(2013)
Ann Oncol.
, vol.24
, Issue.3
, pp. 632-639
-
-
Denkert, C.1
Loibl, S.2
Kronenwett, R.3
Budczies, J.4
von Torne, C.5
Nekljudova, V.6
Darb-Esfahani, S.7
Solbach, C.8
Sinn, B.V.9
Petry, C.10
Muller, B.M.11
Hilfrich, J.12
Altmann, G.13
Staebler, A.14
Roth, C.15
Ataseven, B.16
|